Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.26 USD
-9.24%
Updated:
May 15, 2024
Vivos Therapeutics Inc
Income from Continuing Operations
|
Vivos Therapeutics Inc
Income from Continuing Operations Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Income from Continuing Operations
-$13.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Income from Continuing Operations
$1.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Income from Continuing Operations
$870m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
CVS Health Corp
NYSE:CVS
|
Income from Continuing Operations
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Cigna Corp
NYSE:CI
|
Income from Continuing Operations
$3.9B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Income from Continuing Operations
$400.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
See Also
What is Vivos Therapeutics Inc's Income from Continuing Operations?
Income from Continuing Operations
-13.6m
USD
-13.6m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Income from Continuing Operations amounts to -13.6m USD.
What is Vivos Therapeutics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-10%
-10%
Over the last year, the Income from Continuing Operations growth was 43%. The average annual Income from Continuing Operations growth rates for Vivos Therapeutics Inc have been -4% over the past three years , -10% over the past five years .
You don't have any saved screeners yet
